ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Rallybio Holdings LLC

Rallybio Holdings LLC (RLYB)

1.10
0.00
(0.00%)
Closed September 20 4:00PM
1.10
0.00
(0.00%)
After Hours: 7:50PM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
1.10
Bid
1.10
Ask
1.25
Volume
52,153
1.10 Day's Range 1.13
1.09 52 Week Range 5.03
Market Cap
Previous Close
1.10
Open
1.13
Last Trade Time
Financial Volume
$ 58,311
VWAP
1.1181
Average Volume (3m)
156,125
Shares Outstanding
41,487,586
Dividend Yield
-
PE Ratio
-0.61
Earnings Per Share (EPS)
-1.8
Revenue
-
Net Profit
-74.56M

About Rallybio Holdings LLC

Rallybio Corp is a biopharmaceutical company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. Its lead program is for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening ... Rallybio Corp is a biopharmaceutical company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. Its lead program is for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
-
Rallybio Holdings LLC is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker RLYB. The last closing price for Rallybio was $1.10. Over the last year, Rallybio shares have traded in a share price range of $ 1.09 to $ 5.03.

Rallybio currently has 41,487,586 shares outstanding. The market capitalization of Rallybio is $45.64 million. Rallybio has a price to earnings ratio (PE ratio) of -0.61.

RLYB Latest News

Rallybio to Present Results of Epidemiological Analysis Demonstrating FNAIT Risk Across Racially and Ethnically Diverse Populations at the NORD Breakthrough Summit

Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company translating scientific advances into transformative therapies for patients with devastating rare diseases, announced...

Fierce Names Rallybio to the 2024 Fierce 50 List as an Innovation Honoree

Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company translating scientific advances into transformative therapies for patients with devastating rare diseases, announced...

Rallybio Announces Publication of RLYB212 Phase 1 Proof-of-Concept Study Results in Thrombosis and Haemostasis

– Study Demonstrates that RLYB212 Rapidly Clears HPA-1a Positive Platelets, an Essential Step in Preventing Alloimmunization and FNAIT – – Rallybio On Track to Initiate RLYB212 Phase 2 Dose...

Rallybio to Present at Upcoming Investor Conferences

Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company translating scientific advances into transformative therapies for patients with devastating rare diseases, today...

Rallybio Reports Second Quarter 2024 Financial Results and Provides Business Updates

– On Track to Initiate RLYB212 Phase 2 Dose Confirmation Trial in Pregnant Women at Higher Risk of FNAIT in 4Q 2024 – – $88.6 Million in Cash, Cash Equivalents, and Marketable Securities as of...

Rallybio to Present at the 2024 Jones Healthcare Seaside Summit

Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company translating scientific advances into transformative therapies for patients with devastating rare diseases, today...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.0104-0.9365994236311.11041.19071.1388331.10518549CS
4-0.05-4.347826086961.151.251.09556801.13090853CS
12-0.32-22.53521126761.421.541.091561251.28447832CS
26-0.5-31.251.63.461.098640582.61591572CS
52-3.68-76.98744769874.785.031.095158622.54017241CS
156-11.75-91.43968871612.85211.092272354.05623758CS
260-13.82-92.627345844514.9225.781.092257424.50163792CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
GSIWGarden Stage Ltd
$ 8.17
(259.91%)
70.64M
ZEOZeo Energy Corporation
$ 2.5995
(128.03%)
59.98M
TBIOTelesis Bio Inc
$ 2.9201
(114.71%)
53.74M
NCINeo Concept International Group Holdings Ltd
$ 0.84
(71.43%)
12.68M
VEROVenus Concept Inc
$ 0.8475
(68.66%)
20.56M
HAOHaoxi Health Technology Ltd
$ 0.83
(-72.33%)
8.28M
PGNYProgyny Inc
$ 16.465
(-32.63%)
19.16M
NUZENuZee Inc
$ 0.6998
(-32.06%)
14.06M
RGFReal Good Food Company Inc
$ 0.308
(-28.37%)
363.05k
ALGSAligos Therapeutics Inc
$ 10.18
(-28.11%)
875.5k
NVDANVIDIA Corporation
$ 117.87
(3.97%)
293.54M
SQQQProShares UltraPro Short QQQ
$ 7.76
(-7.62%)
222.56M
HOLOMicroCloud Hologram Inc
$ 0.2328
(15.08%)
120.19M
MAXNMaxeon Solar Technologies Ltd
$ 0.1034
(13.75%)
105.03M
TSLATesla Inc
$ 243.92
(7.36%)
102.7M

Your Recent History

Delayed Upgrade Clock